Sit-stand Desk for Diabetes Prevention
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial tests whether using a sit-stand desk at work can help individuals at risk for type 2 diabetes improve their health. The researchers aim to determine if standing for part of the workday can boost insulin sensitivity and enhance heart health without altering exercise habits. Participants will be divided into three groups: one with no desk changes, one standing for at least 2 hours a day, and another for at least 3 hours. Suitable candidates include those with a sedentary office job, a BMI of 25 or higher, and a risk for diabetes due to prediabetes or other factors. As an unphased trial, this study provides a unique opportunity to explore innovative lifestyle changes that could enhance health.
Do I have to stop taking my current medications for this trial?
The trial protocol does not specify whether you need to stop taking your current medications. However, if you are on diabetes medications or insulin, you are excluded from participating.
What prior data suggests that this sit-stand desk intervention is safe for diabetes prevention?
Research has shown that sit-stand desks are generally safe and easy to use. In a previous study, participants reported no major negative effects. Instead, they experienced benefits such as improved physical health and enhanced mental well-being. Another study found that using sit-stand desks reduced sitting time, which is linked to a lower risk of developing Type 2 Diabetes.
No major safety concerns or harmful side effects were reported with sit-stand desks. Most changes observed were positive, including improved focus at work and reduced fatigue. These desks are designed to help reduce sitting time, potentially improving health without requiring changes to exercise or diet habits.12345Why are researchers excited about this trial?
Researchers are excited about exploring sit-stand desks as a method for diabetes prevention because these desks offer a unique approach compared to traditional lifestyle interventions like medication or intensive exercise programs. Unlike typical treatments that often require significant lifestyle changes or medication adherence, sit-stand desks encourage increased physical activity in a simple and accessible way by allowing users to switch between sitting and standing throughout the workday. This method not only integrates seamlessly into a person's daily routine but also aims to reduce sedentary behavior, a known risk factor for diabetes, potentially leading to improved metabolic health with minimal disruption to daily life.
What evidence suggests that the sit-stand desk intervention is effective for diabetes prevention?
Research has shown that sit-stand desks can improve health by reducing sitting time. In one study, office workers who typically sit for long periods used a sit-stand desk for six months, resulting in a 23% improvement in insulin resistance. Insulin resistance is a risk factor for type 2 diabetes. Long-term use of these desks has also been linked to better blood vessel health and reduced signs of heart disease. Another study found that sit-stand desks helped decrease sitting time at work, which is important because less sitting is associated with better health. This trial will evaluate the effectiveness of sit-stand desks in preventing diabetes. Participants in the 2-Hour Group and 3-Hour Group will use sit-stand desks for at least 2 or 3 hours each workday, respectively, while the Control group will not receive a sit-stand desk. These findings suggest that using a sit-stand desk might help prevent diabetes, especially for those who stand more during the day.34678
Are You a Good Fit for This Trial?
This trial is for sedentary workers at the Medical College of Wisconsin with a BMI over 25, who are at risk for type 2 diabetes due to factors like family history or prediabetes. Participants should not be currently using a standing desk, have no major cardiovascular diseases, musculoskeletal disorders, uncontrolled hypertension, or other specific health conditions.Inclusion Criteria
Exclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Baseline Assessment
Objective assessments of activity levels and sedentary times using an accelerometer for 7 full days
Treatment
Participants are randomized into one of three groups: sit-stand desk intervention targeting 2 hours standing per day, sit-stand desk intervention targeting 3 hours standing per day, or control arm over 6 months
Follow-up
Participants are monitored for changes in insulin sensitivity, metabolic and vascular health
What Are the Treatments Tested in This Trial?
Interventions
- Sit-stand desk intervention
Find a Clinic Near You
Who Is Running the Clinical Trial?
Medical College of Wisconsin
Lead Sponsor